ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-OR034

Residual Kidney Function and Ultrafiltration Rate: Their Association with Mortality

Session Information

Category: Dialysis

  • 607 Dialysis: Epidemiology, Outcomes, Clinical Trials - Non-Cardiovascular

Authors

  • Chou, Jason Albert, UC Irvine, Orange, California, United States
  • Obi, Yoshitsugu, UC Irvine, Orange, California, United States
  • Rhee, Connie, UC Irvine, Orange, California, United States
  • Streja, Elani, UC Irvine, Orange, California, United States
  • Nguyen, Danh V., UC Irvine, Orange, California, United States
  • Soohoo, Melissa, UC Irvine, Orange, California, United States
  • Kovesdy, Csaba P., University of Tennessee Health Science Center, Memphis, Tennessee, United States
  • Sim, John J., Kaiser Permanente Southern California, Pasadena, California, United States
  • Kalantar-Zadeh, Kamyar, UC Irvine, Orange, California, United States
Background

Residual kidney function (RKF) among both peritoneal dialysis and hemodialysis (HD) patients has been associated with improved survival. Although faster ultrafiltration rates (UFR) with HD have been observed to have greater mortality risk among incident HD patients with RKF, the ideal UFR goals are unknown. We hypothesize that in incident HD patients with RKF, a lower UFR will have improved survival.

Methods

We examined the association of RKF measured as Kru (mL/min/1.73m2) and UFR (mL/kg/hr) in combined groups with 1- and 5-year all-cause mortality in a cohort of 34,546 incident HD patients with Cox regression models adjusted for case-mix, comorbidities and selected lab covariates. A total of 9 groups were analyzed, composed of the following groups: Kru <1.5, 1.5-<3.0 and ≥3.0 mL/min/1.73m2 and UFR <6, 6-<10, and ≥10 mL/kg/hr with reference group of Kru ≥3.0 and UFR 6-<10.

Results

We found that Kru-UFR groups with a higher Kru and lower UFR demonstrated a graded association with survival where the Kru ≥3.0 mL/min/1.73m2 and UFR <6 ml/kg/hr group had a 1 year mortality HR (CI 95%) of 0.83 (0.74-0.93) (p-for-interaction 0.002) in the fully adjusted model. All associations were robust to all levels of adjustment on both 1- and 5- year mortality outcomes.

Conclusion

Among incident HD patients with RKF, lower UFR rates were associated with improved survival. Targeting different UFR goals may be a focus of intervention given its potential impact on RKF and mortality.

Figure

Funding

  • NIDDK Support